Help
RSS
API
Feed
Maltego
Contact
Domain > www.beqvez.com
×
More information on this domain is in
AlienVault OTX
Is this malicious?
Yes
No
DNS Resolutions
Date
IP Address
2024-10-04
172.64.151.210
(
ClassC
)
Port 80
HTTP/1.1 301 Moved PermanentlyDate: Fri, 27 Sep 2024 17:32:10 GMTContent-Type: text/htmlContent-Length: 167Connection: keep-aliveCache-Control: max-age3600Expires: Fri, 27 Sep 2024 18:32:10 GMTLocatio html>head>title>301 Moved Permanently/title>/head>body>center>h1>301 Moved Permanently/h1>/center>hr>center>cloudflare/center>/body>/html>
Port 443
HTTP/1.1 200 OKDate: Fri, 27 Sep 2024 17:32:10 GMTContent-Type: text/html; charsetutf-8Transfer-Encoding: chunkedConnection: keep-aliveCF-Ray: 8c9d3b437f1d5ec2-PDXCF-Cache-Status: HITCache-Control: ma !DOCTYPE html>html> head> title>BEQVEZ™ (fidanacogene elaparvovec-dzkt) | An FDA Approved Gene Therapy for Hemophilia B/title> link relcanonical hrefhttps://www.beqvez.com/> meta namedescription contentBEQVEZ™ is a one-time gene therapy infusion used to treat moderate to severe hemophilia B in eligible adult male patients. See risks & important safety info.> meta propertyog:title contentBEQVEZ™ (fidanacogene elaparvovec-dzkt) | An FDA Approved Gene Therapy for Hemophilia B> meta propertyog:description contentBEQVEZ™ is a one-time gene therapy infusion used to treat moderate to severe hemophilia B in eligible adult male patients. See risks & important safety info.> meta propertyog:url contenthttps://www.beqvez.com/> meta propertyog:image contenthttps://www.beqvez.com/media_1a8fbcd7cf3db917053952be230eff421dc4b4c41.png?width1200&formatpjpg&optimizemedium> meta propertyog:image:secure_url contenthttps://www.beqvez.com/media_1a8fbcd7cf3db917053952be230eff421dc4b4c41.png?width1200&formatpjpg&optimizemedium> meta propertyog:image:alt contentTim, an actual BEQVEZTM (fidanacogene elaparvovec- dzkt) patient, playing the guitar with the words "this is me living with hemophilia differently".> meta nametwitter:card contentsummary_large_image> meta nametwitter:title contentBEQVEZ™ (fidanacogene elaparvovec-dzkt) | An FDA Approved Gene Therapy for Hemophilia B> meta nametwitter:description contentBEQVEZ™ is a one-time gene therapy infusion used to treat moderate to severe hemophilia B in eligible adult male patients. See risks & important safety info.> meta nametwitter:image contenthttps://www.beqvez.com/media_1a8fbcd7cf3db917053952be230eff421dc4b4c41.png?width1200&formatpjpg&optimizemedium> meta namealert-top contenton> meta nameviewport contentwidthdevice-width, initial-scale1> script src/scripts/scripts.js typemodule>/script> link relstylesheet href/styles/styles.css> /head> body> header>/header> ma
View on OTX
|
View on ThreatMiner
Please enable JavaScript to view the
comments powered by Disqus.
Data with thanks to
AlienVault OTX
,
VirusTotal
,
Malwr
and
others
. [
Sitemap
]